Skip to main content
Medical information Clinical review pending

Gastroenterology Testing

5-Aminolevulinic Acid (5 ALA) 24 Hour Urine Test

The 5-Aminolevulinic Acid (5 ALA) 24 Hour Urine Test helps diagnose porphyrias, a group of rare metabolic disorders. This test measures 5-ALA levels in urine collected over 24 hours.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
A 10 mL (minimum 5 mL) aliquot of 24-hour urine collection.
Results
Confirm with the laboratory before booking.
Preparation
Collect urine over a 24-hour period. Use a dark-colored container or wrap the container completely in black paper or aluminum foil to protect from light. Record the total volume collected. Refrigerate or freeze the sample before transport.
Test priceKSh 10,400

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the 5-Aminolevulinic Acid (5 ALA) 24 Hour Urine Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Symptoms suggestive of porphyria (e.g., abdominal pain, neurological changes, skin sensitivity)
  • ✓Family history of porphyria
  • ✓Unexplained neurological or psychiatric symptoms
  • ✓Evaluation of certain metabolic disorders
  • ✓Monitoring patients diagnosed with porphyria
02

In plain language

What this test helps you understand

This test is used to aid in the diagnosis of porphyrias, a group of rare genetic disorders affecting the nervous system and skin.
The 5-Aminolevulinic Acid (5 ALA) 24 Hour Urine Test is a specialized diagnostic tool used to detect porphyrias, a group of rare metabolic disorders that can lead to significant health complications. This test measures the concentration of 5-aminolevulinic acid in urine over a 24-hour period, providing essential information for physicians and gastroenterologists in diagnosing and managing these conditions.

This test specifically measures the levels of 5-aminolevulinic acid, which can accumulate in the body in certain metabolic disorders. Elevated levels of this compound in urine may indicate porphyria, which can cause various symptoms and complications if left untreated.

Individuals experiencing symptoms such as abdominal pain, neurological issues, or skin sensitivity may be at risk for porphyrias and should consider this test. Additionally, those with a family history of metabolic disorders or unexplained health issues may benefit from testing.

Early detection of porphyrias can lead to timely intervention and better management of symptoms. Understanding your metabolic health can help prevent complications associated with untreated disorders. This test provides valuable information for healthcare providers in tailoring treatment plans.

Results from the 5-Aminolevulinic Acid 24 Hour Urine Test will indicate the concentration of 5-ALA in your urine. Elevated levels may suggest porphyria, while normal levels can help rule out this condition. It is essential to discuss your results with your healthcare provider for an accurate diagnosis and appropriate management.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationCollect urine over a 24-hour period. Use a dark-colored container or wrap the container completely in black paper or aluminum foil to protect from light. Record the total volume collected. Refrigerate or freeze the sample before transport.
SampleA 10 mL (minimum 5 mL) aliquot of 24-hour urine collection.
MethodologyConfirm with the laboratory before booking.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
Results must be interpreted by a qualified healthcare professional. Factors like diet, medications, and certain medical conditions can potentially influence test results. Uncovered samples exposed to light are unacceptable.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Porphyrias are a group of rare genetic disorders that affect the body's ability to produce heme, a component of hemoglobin. This can lead to a buildup of certain chemicals, causing various symptoms.
Collecting urine over 24 hours provides a more accurate measure of the amount of 5-ALA excreted by the body compared to a single spot sample.
You will need to collect all urine produced over a 24-hour period in a special container. Ensure the container is protected from light. Follow the specific instructions provided by the laboratory.
Elevated levels of 5-ALA in the urine may suggest the presence of certain types of porphyria. Your doctor will interpret this result along with your symptoms and other tests.
The urine collection itself is not painful. It involves urinating into a collection container over a day.
Turnaround time varies. Please confirm the expected timeframe with the laboratory before booking your test.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp